[ESPR] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -9.14%
YoY- -10.38%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 982 145,419 184,474 0 0 0 0 -
PBT -54,221 87,379 -60,039 -49,911 -45,730 -46,130 -37,891 27.06%
Tax 0 0 -74 0 0 0 807 -
NP -54,221 87,379 -60,039 -49,911 -45,730 -46,130 -37,891 27.06%
Tax Rate - 0.00% - - - - - -
Total Cost 55,203 58,040 244,513 49,911 45,730 46,130 37,891 28.60%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -5,521.49 60.09 -32.55 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -2.01 3.26 -2.24 -1.86 -1.71 -1.73 -1.44 24.97%
EPS Diluted -2.01 3.07 -2.24 -1.86 -1.71 -1.73 -1.44 24.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.